Cargando…
TOF(IMS) mass spectrometry-based immunopeptidomics refines tumor antigen identification
T cell recognition of human leukocyte antigen (HLA)-presented tumor-associated peptides is central for cancer immune surveillance. Mass spectrometry (MS)-based immunopeptidomics represents the only unbiased method for the direct identification and characterization of naturally presented tumor-associ...
Autores principales: | Hoenisch Gravel, Naomi, Nelde, Annika, Bauer, Jens, Mühlenbruch, Lena, Schroeder, Sarah M., Neidert, Marian C., Scheid, Jonas, Lemke, Steffen, Dubbelaar, Marissa L., Wacker, Marcel, Dengler, Anna, Klein, Reinhild, Mauz, Paul-Stefan, Löwenheim, Hubert, Hauri-Hohl, Mathias, Martin, Roland, Hennenlotter, Jörg, Stenzl, Arnulf, Heitmann, Jonas S., Salih, Helmut R., Rammensee, Hans-Georg, Walz, Juliane S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656517/ https://www.ncbi.nlm.nih.gov/pubmed/37978195 http://dx.doi.org/10.1038/s41467-023-42692-7 |
Ejemplares similares
-
Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
por: Nelde, Annika, et al.
Publicado: (2022) -
Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
por: Wacker, Marcel, et al.
Publicado: (2023) -
Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
por: Nelde, Annika, et al.
Publicado: (2021) -
Immunopeptidome Diversity in Chronic Lymphocytic Leukemia Identifies Patients with Favorable Disease Outcome
por: Marconato, Maddalena, et al.
Publicado: (2022) -
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
por: Tegeler, Christian M., et al.
Publicado: (2022)